Followers | 117 |
Posts | 10384 |
Boards Moderated | 1 |
Alias Born | 11/27/2015 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, September 19, 2017 9:40:35 PM
https://www.accessdata.fda.gov/scripts/cber/CFAppsPub/Index.cfm?fuseAction=fuse_DisplayDetails
I do appreciate his input, whether I like it or not. I'm happy his company is private so it doesn't affect our share price. If Kristin Comella compromises with the FDA then USRM, Patients, and Investors all have a lot to gain from it. Kristin Comella realizes that and she is just in a bargaining stage with the FDA. However in the meantime are competitors who have approval are going to grow soon and faster. So if they have comments whether useful or annoying, let's learn from it what we can and start growing too.
If you are a potential patient wouldn't you want to choose a facility with an FDA approval over one who isn't. However as an investor wouldn't you want to invest in a company who will soon be FDA approved, rather than that one which already is. Of course, once a compromise is made, kaboom we go way up. Go USRM $$$$$
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM